DanCann Pharma AS (STU:DAN0) Total Operating Expense: €0.93 Mil (TTM As of Sep. 2025)


STU:DAN0 DanCann Pharma AS STU:DAN0
27 GF Score
Price €0.00
! 3 Warning Signs
View Full Analysis

What is DanCann Pharma AS Total Operating Expense?

DanCann Pharma AS STU:DAN0 27 Total Operating Expense is €0.93 Mil as of Sep. 2025. GuruFocus rates STU:DAN0 with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

DanCann Pharma AS's Total Operating Expense for the three months ended in Sep. 2025 was €0.22 Mil. DanCann Pharma AS's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 was €0.93 Mil.

DanCann Pharma AS Total Operating Expense Related Terms

DanCann Pharma AS Total Operating Expense Historical Data

* Premium members only.

The historical data trend for DanCann Pharma AS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Total Operating Expense Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial 0.41 1.08 1.45 1.72 0.91

DanCann Pharma AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.24 0.24 0.22
STU:DAN0
27GF Score
DanCann Pharma AS STU:DAN0
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DanCann Pharma AS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €0.93 Mil mean?
DanCann Pharma AS (STU:DAN0) has a Total Operating Expense of €0.93 Mil as of Sep. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on DanCann Pharma AS and its competitors.
Is DanCann Pharma AS's Total Operating Expense too high?
DanCann Pharma AS's current Total Operating Expense is €0.93 Mil. Overall, DanCann Pharma AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Total Operating Expense compare to ZTS and UTHR?
DanCann Pharma AS's Total Operating Expense of €0.93 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on DanCann Pharma AS and its competitors. DanCann Pharma AS's current Total Operating Expense is €0.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (STU:DAN0) has a current Total Operating Expense of €0.93 Mil. The current Total Operating Expense is €0.93 Mil. DanCann Pharma AS's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For DanCann Pharma AS (STU:DAN0), the current Total Operating Expense is €0.93 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DanCann Pharma AS Business Description

Address Rugvaenget 5, Ansager, DNK, DK-6823
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
27GF Score

Get the complete analysis for STU:DAN0

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price